Latest in News & Research
Wildfire Air Pollution Tied to Uptick in Visits for Dermatitis, Itch
Increased health care utilization seen for pediatric and adult patients
Bimekizumab Tops Secukinumab for Plaque Psoriasis
In second study, bimekizumab showed noninferiority and superiority to adalimumab for moderate-to-severe disease
Psoriasis Incidence in the United States Remains Steady
New diagnosis of psoriasis increases with age, is similar between sexes, and is greatest among Whites
Composite Perineural Invasion Score IDs Outcome in Cutaneous SCC
Composite PNI score, calculated from five histopathologic features, is strongest predictor of adverse outcome
Most Mohs Surgeons Recommend Nicotinamide for KC Prevention
Individuals with safety concerns relating to long-term use and in practice for more than 10 years less likely to recommend
Cutaneous AEs Linked to Immune Checkpoint Inhibitor Therapy
Cutaneous immune-related adverse events seen in 25 percent of cancer patients initiating ICI therapy with median onset time of 113 days
Chronic Adverse Effects From Anti-PD-1 Immunotherapies Common
About 43 percent of patients who receive anti-PD1 therapy for advanced melanoma have chronic immune-related adverse effects
Children With Worse Atopic Dermatitis More Likely to Have Learning Disabilities
Findings independent of socioeconomic characteristics, onset age, and other related disorders
Nonmedical Switch From Adalimumab Originator to Biosimilars Feasible
Findings show no change in drug retention or effectiveness from before to after the switch
Gene Test Increasingly Used for Melanoma Assessment
National survey of dermatologists shows that majority believes panel has clinical, patient benefits
Skin Reactions Usually Mild After COVID-19 Vaccination
Most common were delayed large local reactions, followed by local injection site reactions, urticarial eruptions, morbilliform eruptions
Could Widely Used Blood Pressure Meds Raise Skin Cancer Risk?
By Physician’s Briefing Staff
Banning Youth Use of Tanning Bed Would Be Cost-Effective
Ban could reduce the number of melanoma cases and decrease lifetime health care costs, despite compliance costs
Thiazides May Up Risk for Skin Cancer in Older Adults
Increased exposure linked to significantly increased rates of incident keratinocyte carcinoma, melanoma in adults ≥66 years
Screening May Improve Early Detection for Melanoma-Prone
Reduced thickness of melanoma lesions seen for patients receiving routine skin cancer screening, education about self-exam
Global Burden of Melanoma Considerable, Set to Rise by 2040
If 2020 rates continue, burden estimated to increase by about 50 percent for incidence, 68 percent for deaths by 2040
Actinic Keratosis Diagnosis Ups Cumulative Risk for Skin Cancer
Older age is strong risk factor for cutaneous squamous cell carcinoma, independent of actinic keratosis diagnosis
Genetic, Environmental Prenatal Risk Factors Play Role in Early Atopic Dermatitis
Nonmodifiable risk factors include gestational diabetes, maternal history of allergy, prenatal history of eczema
Infant skin infections associated with the development of childhood psoriasis
Among patients with plaque phenotype, high disease activity, and scalp lesions, 52 percent developed severe disease
20 of 1292